We Work For Health recently unveiled a new set of one-page resources designed to highlight the significant impact of the biopharmaceutical industry in each of the 50 U.S. states, D.C. and Puerto Rico.
These resources provide an overview of job, vendor and clinical trial data that contribute to local economies – helping to drive innovation and workforce economics in every state across the nation.
In total, the industry directly employed 1M+ people and supported 4.9M+ total jobs in 2022; spent $71.6B+ with vendors in 2022 across 15 of the largest biopharmaceutical companies; and supported 88K+ clinical trials in the last five years.
Visit our “In the States” page to download the state one pagers. You can also view and download state vendor data by Congressional and State Legislative districts.
The biopharmaceutical industry is a vibrant cornerstone of the American economy, supporting a robust and diverse workforce, fostering groundbreaking research, delivering cutting-edge therapies for patients in need and so much more. These new state-by-state resources aim to give policymakers, community leaders, and the general public a better understanding of the life sciences sector’s critical role in driving economic growth, innovation and job creation.
To learn more about We Work For Health and our mission to support policies that foster innovation and facilitate the delivery of lifesaving and life-enhancing medicines, visit our In the States, Policy Framework, and Resources pages.